Early Antipsychotic Nonresponse as a Predictor of Nonresponse

<p>In this episode, we discuss whether early nonresponse in adolescents with first-episode psychosis predicts longer-term nonresponse and nonremission. We also explain when it is most likely that symptom improvement occurs and some other considerations when there is nonresponse.</p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC210" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-03-2742?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC210" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: CAP Smart Takes Vol. 03</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/early-antipsychotic-nonresponse-as-a-predictor-of-nonresponse-in-adolescents-with-psychosis-2742-5294?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC210" target="_blank" rel="noopener"><strong>Early Antipsychotic Nonresponse as a Predictor of Nonresponse in Adolescents With Psychosis</strong></a></li> </ul>